title: Transcriptional and posttranscriptional regulation of the proopiomelanocortin gene in the pars intermedia of the pituitary gland of Xenopus laevis.
abstract: In the melanotrope cells of the intermediate pituitary gland of the amphibian Xenopus laevis, expression of the POMC gene is under physiological control, i.e. it is 20- to 30-fold higher in animals adapted to a black background compared to animals adapted to a white background. To investigate whether changes in POMC messenger RNA stability contribute to this difference in expression, a steady state kinetic model for mRNA degradation was used to determine the half-life of POMC mRNA during the induction and deinduction of POMC gene expression in melanotrope cells. During induction of the POMC gene the half-life of POMC mRNA was 3- to 4-fold longer than during deinduction. This difference in mRNA stability is, however, not sufficient to account for the 20- to 30-fold difference in the steady state levels of POMC mRNA between the two physiological conditions. Results from experiments with the protein synthesis inhibitor cycloheximide and the mRNA synthesis inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzidimidazole suggest 1) that during induction of POMC gene expression no de novo protein synthesis is required and, 2) that deinduction of POMC gene expression requires transcriptional activation of an mRNA-degradation system. Pulse-labeling experiments with [3H]uridine showed that in neurointermediate lobes of white-adapted animals there is an 8-fold higher amount of newly synthesized POMC mRNA than in lobes of black animals. This suggests a fast in vitro induction of POMC gene transcription. The dopamine D2-receptor agonist apomorphine decreased POMC mRNA biosynthesis about 5-fold, which confirms that regulation of POMC gene expression includes a transcriptional component. In conclusion, our results demonstrate that during the physiological process of background adaptation the regulation of POMC gene expression in Xenopus melanotrope cells is exerted by alterations in POMC gene transcription as well as in POMC mRNA stability.
authors.affiliation: Department of Animal Physiology, University of Nijmegen, The Netherlands.
authors.forename: T A
authors.initials: TA
authors.lastname: Ayoubi
authors.forename: B G
authors.initials: BG
authors.lastname: Jenks
authors.forename: E W
authors.initials: EW
authors.lastname: Roubos
authors.forename: G J
authors.initials: GJ
authors.lastname: Martens
mesh_terms: D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004004:Dichlororibofuranosylbenzimidazole / Q000494:pharmacology*; D005786:Gene Expression Regulation; D007700:Kinetics; D008433:Mathematics; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology*; D011333:Pro-Opiomelanocortin / Q000235:genetics*; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D014158:Transcription, Genetic; D014982:Xenopus laevis
chemical_list: D012333:RNA, Messenger; D004004:Dichlororibofuranosylbenzimidazole; D011333:Pro-Opiomelanocortin; D003513:Cycloheximide; D001058:Apomorphine